Battling microbial infection

Available in the UK from Alpha Laboratories, QuickFISH enables a targeted, species specific, antimicrobial therapeutic strategy to be employed much sooner, by enabling species ID to be reported at the same time as the gram stain result.

This is especially helpful when dealing with microorganisms that share an identical morphology when viewed under gram stain.

Organisms that QuickFISH can distinguish include Staphylococci, gram negative rods, Enterococci and Candida. These organisms can often be the cause of life threatening blood infections and sepsis.

The QuickFISH assay can help deliver decreased use of broad spectrum antibiotics, reduced time to optimised antibiotic therapy, control of the spread of antimicrobial resistance, decreased length of hospital stays and lower healthcare costs. 

As the incidence of antibiotic resistance continues to increase, the supply of effective new antibiotics has all but dried up, and there are decreasing treatment options for bacterial infections.

Clinicians face the challenge of ensuring early, appropriate and effective antibiotic therapy for patients with critical infections, while avoiding the unnecessary use of broad-spectrum antimicrobials that can lead to increased antibiotic resistant bacteria.